Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Neoplasms 3 Colonic Neoplasms 3 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Ornithine Carbamoyltransferase Deficiency Disease 1 Obesity, Morbid 1 Neurologic Manifestations 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Gynecological Cancer 1 Genital Diseases, Female 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1

Interventions

Cisplatin 22 pembrolizumab 21 Carboplatin 12 Radiotherapy 11 Paclitaxel 11 Brachytherapy 11 Drug Therapy 10 Bevacizumab 9 Blood Specimen Collection 7 Colposcopy 6 Specimen Handling 5 Injections 5 toripalimab 4 Taxes 4 Surveys and Questionnaires 4 Nivolumab 4 Mass Screening 4 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Chemotherapy, Adjuvant 4 Chemoradiotherapy 4 spartalizumab 3 lenvatinib 3 camrelizumab 3 aldesleukin 3 Restraint, Physical 3 Radiation 3 Fulvestrant 3 Cyclophosphamide 3 Biopsy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Uterine Cervical Neoplasms × Laparoscopy × Clear all

NCT06489795 2025-02-03

G-LACC

Hannover Medical School

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡